JPRN-UMIN000003830
Completed
未知
Effect of pioglitazone and metformin in combination with insulin therapy in patients with type 2 diabetes - Effect of pioglitazone and metformin in combination with insulin therapy in patients with type 2 diabetes
ConditionsType 2 diabetes
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Type 2 diabetes
- Sponsor
- Chigasaki Municipal Hospital
- Enrollment
- 250
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\) Patients with type 1 diabetes 2\) Patients receiving thiazolidiones or biguanides 3\) Heart failure defined as NYHA class III or above 4\) Having allergy to thiazolidiones or biguanides 5\) Patients with severe liver failure or renal failure 6\) History of acute coronary syndrome or cerebrovascular accident with in 3 months 7\) Pregnant or breastfeeding 8\) Patients with familial hypercholesterolemia 9\) Other patients determined to be inappropriate by physician
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Not Applicable
Effects of a Pioglitazone/ Metformin Fixed Combination in Comparison to Metformin in Combination with Glimepiride on Diabetic DyslipidemiaPatients with Type 2 Diabetes mellitus (HbA1c > 6.5% and >/ = 9%) and diabetic dylipidemia inefficiently treated with Metformin monotherapy (maximal individually tolerated dose) will be eligible for this trial.MedDRA version: 8.1Level: LLTClassification code 10063624Term: Type II diabetes mellitus inadequate controlEUCTR2006-004455-37-DETakeda Pharma GmbH260
Active, not recruiting
Not Applicable
Impact of Pioglitazone, Metformin and the combination of both on cardiovascular risk in insulin-treated patients with Type 2 diabetes – The PIOcomb Study - PIOcomb StudyEUCTR2007-006706-14-ATTakeda Pharma GmbH200
Active, not recruiting
Not Applicable
Impact of Pioglitazone, Metformin and the combination of both on cardiovascular risk in insulin-treated patients with Type 2 diabetes – The PIOcomb Study - PIOcomb StudyDiabetes mellitus type 2MedDRA version: 9.1Level: LLTClassification code 10045242Term: Type II diabetes mellitusEUCTR2007-006706-14-DETakeda Pharma GmbH
Completed
Not Applicable
Differential effects of metformin and pioglithazone on hs-CRP in patients with type II DM.diabetes mellitus II.non-insulin-dependent diabetes mellitusIRCT201109067482N1Qazvin University of Medical Sciences40
Completed
Not Applicable
Comparative Efficacy of Pioglitazone and Metformin in Glucose Variability in Type 2 Diabetestype 2 diabetesJPRN-UMIN000001891Jikei University School of Medicine20